丹纳赫预计业绩将达先前指引高端

环球市场播报
Jan 12

  丹纳赫(Danaher)预计,受生物加工业务表现强劲的提振,第四财季收入增长和全年收益都将接近该公司先前业绩预期的上限。

  该公司表示,预计第四财季经调整的核心收入增长将接近其先前给出的低个位数百分比增长这一业绩预期的上限。

  该公司还表示,预计2025整个财年经调整后每股收益将接近先前预测的7.70美元至7.80美元区间的上限。

  首席执行官雷纳·布莱尔(Rainer Blair)表示:“我们对第四财季生物加工业务的持续强劲表现以及生命科学和诊断业务收入好于预期感到尤其满意。”

海量资讯、精准解读,尽在新浪财经APP

责任编辑:李桐

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10